This website will be unavailable Sunday, June 29 between 6:00 a.m. and 5:00 p.m. for maintenance.
LEGISLATIVE BUDGET BOARD
Austin, Texas
FISCAL NOTE, 89TH LEGISLATIVE REGULAR SESSION
May 20, 2025
TO:
Honorable Gary VanDeaver, Chair, House Committee on Public Health
FROM:
Jerry McGinty, Director, Legislative Budget Board
IN RE:
SB261 by Perry (Relating to a prohibition on the offering for sale and the sale of cell-cultured protein for human consumption; providing civil and criminal penalties.), Committee Report 2nd House, Substituted
No significant fiscal implication to the State is anticipated.
It is assumed that any costs associated with the bill could be absorbed using existing resources.
According to the Comptroller of Public Accounts, under current law, a violation under Chapter 431 is subject to assessment of civil and administrative penalties. The number of violations of the amendments to the chapter proposed by the bill that would result in civil or administrative penalty revenue is unknown; therefore, the related fiscal impact on the state cannot be estimated for fiscal years 2026-27. As the prohibitions expire September 1, 2027, there would be no violations subject to penalties and no fiscal impact after that date.
Local Government Impact
No significant fiscal implication to units of local government is anticipated.
Source Agencies:
212 Office of Court Administration, Texas Judicial Council, 304 Comptroller of Public Accounts, 537 State Health Services, Department of